83Bar
Austin, US · Founded 2020 · Delaware corporation · 2 known investors
Founders & leadership
TK
Terence K. O'HaraExecutive
RS
Randy ScottExecutive
SN
Seth NelsoninExecutive
RB
Robert BaurysNamed on SEC filing
KT
K Terence O'HaraNamed on SEC filing
AW
Anthony WilliamsNamed on SEC filing
Board
MS
Mark SummersBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.6M disclosed across 3 rounds · 2023–2025
▶$7.5MraisedDec 2025 · 15 investors · Other Health CareRule 506(b)
▶$7.5MraisedDec 2025 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark SummersDirector
- Seth NelsonExecutive Officer, Director
- Robert BaurysDirector
- Robert RebakDirector
- Randy ScottDirector
- Terry O'HaraExecutive Officer
- Offering amount
- $9M
- Amount sold
- $7.5M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$4.6MraisedApr 2025 · 5 investors · Other Health CareRule 506(b)
▶$4.6MraisedApr 2025 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Terence K. O'HaraExecutive Officer
- Robert BaurysDirector
- Mark SummersDirector
- Randy ScottExecutive Officer, Director
- Seth NelsonExecutive Officer, Director
- Offering amount
- $9.5M
- Amount sold
- $4.6M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.5MraisedOct 2023 · 1 investors · Other Health CareRule 506(b)
▶$2.5MraisedOct 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark SummersDirector
- Randy ScottExecutive Officer, Director
- K Terence O'HaraExecutive Officer
- Robert BaurysDirector
- Anthony WilliamsDirector
- Offering amount
- $3.5M
- Amount sold
- $2.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapPower6 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Sano Genetics5 shared keywordsSano provides a platform combining genetic testing, patient recruitment, and engagement tools for precision medicine clinical trials. The platform helps research teams enroll participants and manage operations more efficiently in precision medicine studies.
Companies competing with 83Bar for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are 83Bar's investors?
- 83Bar's investors include HCAP Partners, Bigfoot Capital.
- How much funding has 83Bar raised?
- 83Bar has disclosed $14.6M raised across 3 rounds.
- Where is 83Bar headquartered?
- 83Bar is headquartered in Austin, US.